Sentry Investment Management’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-43,016
Closed -$4.27M 454
2019
Q3
$4.27M Buy
43,016
+290
+0.7% +$27.6K 0.28% 98
2019
Q2
$3.95M Hold
42,726
0.26% 96
2019
Q1
$4.03M Sell
42,726
-3,764
-8% -$329K 0.28% 89
2018
Q4
$2.98M Sell
46,490
-1,194
-3% -$88.1K 0.22% 120
2018
Q3
$4.27M Hold
47,684
0.26% 101
2018
Q2
$3.79M Sell
47,684
-8,064
-14% -$670K 0.25% 103
2018
Q1
$4.97M Sell
55,748
-6,604
-11% -$634K 0.3% 84
2017
Q4
$6.51M Sell
62,352
-24
-0% -$2.71K 0.35% 73
2017
Q3
$9.1M Sell
62,376
-41
-0.1% -$5.58K 0.34% 48
2017
Q2
$8.11M Buy
62,417
+619
+1% +$75.8K 0.32% 50
2017
Q1
$7.69M Sell
61,798
-1,463
-2% -$175K 0.31% 50
2016
Q4
$7.32M Buy
63,261
+60
+0.1% +$6.68K 0.31% 54
2016
Q3
$6.61M Buy
63,201
+1,277
+2% +$138K 0.29% 58
2016
Q2
$6.11M Sell
61,924
-18
-0% -$1.86K 0.27% 61
2016
Q1
$6.2M Hold
61,942
0.28% 58
2015
Q4
$7.42M Sell
61,942
-38,072
-38% -$4.4M 0.34% 51
2015
Q3
$10.8M Buy
100,014
+10,333
+12% +$1.28M 0.53% 33
2015
Q2
$10.4M Buy
89,681
+12,368
+16% +$1.41M 0.49% 37
2015
Q1
$8.91M Buy
77,313
+6,660
+9% +$796K 0.42% 43
2014
Q4
$7.9M Buy
70,653
+3,400
+5% +$359K 0.38% 45
2014
Q3
$6.37M Sell
67,253
-2,343
-3% -$211K 0.33% 53
2014
Q2
$5.98M Buy
69,596
+22,396
+47% +$1.7M 0.31% 55
2014
Q1
$3.29M Hold
47,200
0.17% 96
2013
Q4
$3.99M Buy
47,200
+20,000
+74% +$1.58M 0.22% 74
2013
Q3
$2.1M Buy
27,200
+10,400
+62% +$729K 0.12% 127
2013
Q2
$983K Buy
+16,800
New +$1.01M 0.06% 158

Other funds holding CELG

Sentry Investment Management's CELG Position: Q4 2019 in Review

Sentry Investment Management sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 43,016 shares — an estimated $4.27M sold.

Sentry Investment Management first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $10.8M in Q3 2015. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Sentry Investment Management reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Sentry Investment Management sold 43,016 Celgene Corp shares in Q4 2019, an estimated $4.27M.
  • Sentry Investment Management first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
  • Sentry Investment Management's Celgene Corp position peaked at $10.8M in Q3 2015.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Sentry Investment Management's 13F filing for Q4 2019, filed 6 Feb 2020.